Screen with the MIOS before administering the CIMI-M and deploy it at intake or before trauma treatment¶

Strategy · All strategies
Evidence · no claims cited

Description¶

The authors give concrete deployment guidance: the CIMI-M complements intake procedures and should be administered only when a patient reports a PMIE, with a brief self-report screen first. They write, "We recommend administering the MIOS [5] prior to the CIMI-M to screen for PMIE exposure, to determine whether the interview is warranted." They further suggest conducting it during the intake phase or immediately before trauma treatment, optionally alongside PTSD assessment such as the CAPS-5, and caution that its at-least-90-minute duration requires weighing participant burden when combined with other assessments.

Design Implications¶

Context¶

Requirements¶

• A prior MIOS screening indicating PMIE exposure
• Scheduling at least 90 minutes for the interview

Constraints¶

• Should only be administered when patients report a PMIE
• Clinicians should carefully consider participant burden when combining it with multiple assessments given its duration

Target Learners¶

• clinicians conducting veteran intake and treatment planning

Target Learning Goals¶

• selecting veterans for whom descriptive moral injury assessment is warranted
• sequencing assessment within intake and treatment workflows

Related Strategies¶

• Cimi M Clinical Interview
• Provide brief interviewer training on the moral injury concept and interview structure

Examples¶

-

Key Sources¶

• de Goede, M. L., Boelen, P. A., Litz, B. T., & ter Heide, F. J. J. (2026). Mapping moral injury: Development and feasibility of the Clinical Interview for Moral Injury—military version (CIMI-M). PLOS One. https://doi.org/10.1371/journal.pone.0359553